Sugar-coated killer: serotype 3 pneumococcal disease
JN Luck, H Tettelin, CJ Orihuela - Frontiers in Cellular and Infection …, 2020 - frontiersin.org
Capsular polysaccharide (CPS), which surrounds the bacteria, is one of the most significant
and multifaceted contributors to Streptococcus pneumoniae virulence. Capsule prevents …
and multifaceted contributors to Streptococcus pneumoniae virulence. Capsule prevents …
New insights into the mycobacterial PE and PPE proteins provide a framework for future research
LS Ates - Molecular microbiology, 2020 - Wiley Online Library
The PE and PPE proteins of Mycobacterium tuberculosis have been studied with great
interest since their discovery. Named after the conserved proline (P) and glutamic acid (E) …
interest since their discovery. Named after the conserved proline (P) and glutamic acid (E) …
Nationwide trends of invasive pneumococcal disease in Spain from 2009 through 2019 in children and adults during the pneumococcal conjugate vaccine era
S de Miguel, M Domenech… - Clinical Infectious …, 2021 - academic.oup.com
Background Introduction of pneumococcal conjugate vaccines (PCVs) has reduced the
disease caused by vaccine serotypes in children, providing herd protection to adults …
disease caused by vaccine serotypes in children, providing herd protection to adults …
The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi
Streptococcus pneumoniae causes substantial mortality among children under 5-years-old
worldwide. Polysaccharide conjugate vaccines (PCVs) are highly effective at reducing …
worldwide. Polysaccharide conjugate vaccines (PCVs) are highly effective at reducing …
Rapid inference of antibiotic resistance and susceptibility by genomic neighbour typing
Surveillance of drug-resistant bacteria is essential for healthcare providers to deliver
effective empirical antibiotic therapy. However, traditional molecular epidemiology does not …
effective empirical antibiotic therapy. However, traditional molecular epidemiology does not …
Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of …
HL Sings, P De Wals, BD Gessner… - Clinical Infectious …, 2019 - academic.oup.com
The 13-valent pneumococcal conjugate vaccine (PCV13) is the only licensed PCV with
serotype 3 polysaccharide in its formulation. Postlicensure PCV13 effectiveness studies …
serotype 3 polysaccharide in its formulation. Postlicensure PCV13 effectiveness studies …
Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate …
R Kaur, N Fuji, ME Pichichero - European Journal of Clinical Microbiology …, 2022 - Springer
The otopathogens colonizing the nasopharynx (NP) and causing acute otitis media (AOM)
have shown dynamic changes following introduction of pneumococcal conjugate vaccines …
have shown dynamic changes following introduction of pneumococcal conjugate vaccines …
Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018
Streptococcus pneumoniae continues to cause significant disease burden. Whilst
pneumococcal conjugate vaccines (PCV) have substantially reduced this burden, serotype …
pneumococcal conjugate vaccines (PCV) have substantially reduced this burden, serotype …
Factors affecting antimicrobial resistance in Streptococcus pneumoniae following vaccination introduction
ER Watkins, A Kalizang'Oma, A Gori, S Gupta… - Trends in …, 2022 - cell.com
Streptococcus pneumoniae is a major cause of pneumonia, meningitis, and septicaemia
worldwide. Pneumococcal antimicrobial resistance (AMR) has been highlighted by the WHO …
worldwide. Pneumococcal antimicrobial resistance (AMR) has been highlighted by the WHO …
Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader
Despite its inclusion in pneumococcal conjugate vaccine 13 (PCV13), Streptococcus
pneumoniae serotype 3 remains a major cause of invasive pneumococcal disease in …
pneumoniae serotype 3 remains a major cause of invasive pneumococcal disease in …